Compare ADVB & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADVB | CYCU |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 9.5M |
| IPO Year | 2023 | 2021 |
| Metric | ADVB | CYCU |
|---|---|---|
| Price | $8.32 | $0.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 176.0K | ★ 35.3M |
| Earning Date | 05-14-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.21 | N/A |
| Revenue | N/A | ★ $17,771,485.00 |
| Revenue This Year | N/A | $8.92 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | $1.54 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.19 | $0.16 |
| 52 Week High | $24.23 | $7.13 |
| Indicator | ADVB | CYCU |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | N/A |
| Support Level | $3.95 | N/A |
| Resistance Level | $9.50 | N/A |
| Average True Range (ATR) | 1.02 | 0.00 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 56.49 | 0.00 |
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).